Quick Takeaways
- Bleichroeder LP filed SCHEDULE 13G for Cellectar Biosciences, Inc. Common Shares (CLRB).
- Disclosed ownership: 6.1%.
- Date of event: 30 Sep 2025.
Bleichroeder LP - 30 Sep 2025 SCHEDULE 13G Report for Cellectar Biosciences, Inc. Common Shares (CLRB)
- Filing Manager
- Bleichroeder LP
- Reporting Manager
- Bleichroeder LP
- Symbol
- CLRB
- Shares outstanding
- 3,289,474 shares
- Disclosed Ownership
- 200,000 shares
- Ownership
- 6.1%
- Form type
- SCHEDULE 13G
- Filing time
- 14 Nov 2025, 10:46:47 UTC
- Date of event
- 30 Sep 2025
- Next filing
- 13 Feb 2026
- SEC
- View on sec.gov
Quoteable Key Fact
"Bleichroeder LP disclosed 6.1% ownership in Cellectar Biosciences, Inc. Common Shares (CLRB) on 30 Sep 2025."
What Changed
- No earlier schedule filing is available for direct comparison.
- Current filing was accepted on 14 Nov 2025, 10:46.
Why This Matters
- This page explains what this Schedule 13D/13G filing tells you before manager-level rows.
- You can verify ownership claims directly against the original SEC filing.
Source Evidence
Backed by Schedule 13D/13G
See Original Filing
Beneficial ownership values are sourced from the original SEC Schedule 13D/13G filing.
Reporting Managers (3)
| Name | Ownership | Shares Owned | sole voting power | shared voting power | Signature | Title | CIK |
|---|---|---|---|---|---|---|---|
| Bleichroeder LP | 6.1% | 200,000 | 200,000 | 0 | Andrew Gundlach | President and CEO | |
| Bleichroeder Holdings LLC | 6.1% | 200,000 | 200,000 | 0 | Andrew Gundlach | President and CEO | |
| Andrew Gundlach | 6.1% | 200,000 | 200,000 | 0 | Andrew Gundlach | Individual |